Genentech - PDFSEARCH.IO - Document Search Engine

Genentech
Results: 384

#	Item
341	Roche Singapore Technical Operations Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:03 Pharmacology Medicine Bevacizumab Trastuzumab Hillsboro Oregon Rituximab Oregon Genentech South San Francisco California Orphan drugs
342	Backgrounder Media Contact: Caroline Pecquet[removed]Biotech Manufacturing Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:03 Biotechnology Genentech South San Francisco California Biologic Food and Drug Administration Pharmaceutical industry in India Biosimilar Biopharmaceutical Pharmacology Pharmaceutical sciences Clinical research
343	April[removed]IMPORTANT DRUG WARNING Regarding AVASTIN® (bevacizumab) Dear Healthcare Provider: Genentech, Inc. would like to inform you of important new safety information regarding Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Gastrointestinal cancer Bevacizumab Genentech Fistula Colorectal cancer Small-cell carcinoma Non-small-cell lung carcinoma Food and Drug Administration Esophageal cancer Medicine Oncology Lung cancer
344	July[removed]IMPORTANT DRUG WARNING SUBJECT: Microangiopathic Hemolytic Anemia (MAHA) in Patients treated with Avastin® (bevacizumab) and sunitinib malate Dear Healthcare Provider: Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:12 Sunitinib Genentech Renal cell carcinoma Schistocyte Food and Drug Administration Thrombocytopenia Microangiopathic hemolytic anemia Medicine Pharmacology Bevacizumab
345	trim: 8.5" safety: 7.5" September[removed]IMPORTANT DRUG WARNING Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:13 Bevacizumab Food and Drug Administration Genentech Adverse effect MedWatch Medicine Pharmacology Health
346	IMPORTANT DRUG WARNING 1 DNA Way South San Francisco, CA 94080 Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 B-cell chronic lymphocytic leukemia Leukemia Plateletpheresis Rituximab Chlorambucil Genentech MedWatch Medicine Hematopathology Thrombocytopenia
347	Energy and water graphs.xls Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:03 Genentech South San Francisco California Business Vacaville California Arthur D. Levinson Corporate sustainability Corporate social responsibility Business ethics Geography of California Applied ethics
348	November 18th, 2011 IMPORTANT PRESCRIBING INFORMATION FDA COMMISSIONER REVOKES APPROVAL OF AVASTIN FOR TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER (mBC) IN THE UNITED STATES Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Bevacizumab Ribbon symbolism Genentech Colorectal cancer Food and Drug Administration Breast cancer Metastatic breast cancer Presumed ocular histoplasmosis syndrome Medicine Pharmacology Oncology
349	October 2009 IMPORTANT DRUG WARNING Regarding RITUXAN® (Rituximab) Dear Healthcare Professional: Genentech, Inc. and Biogen Idec, Inc. would like to inform you of important new safety information regarding Rituxan (ritu Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:11 Immunosuppressants Rituximab Monoclonal antibodies Biogen Idec JC virus Autoimmune diseases Progressive multifocal leukoencephalopathy Genentech Rheumatoid arthritis Medicine Health Pharmacology
350	February[removed]COUNTERFEIT PRODUCT LABELED AS AVASTIN® (bevacizumab) IN THE UNITED STATES IMPORTANT Add to Reading List Source URL: www.gene.com Language: English - Date: 2014-03-31 07:24:10 Medicine Bevacizumab Food and Drug Administration Genentech Office of Criminal Investigations Counterfeit medications Counterfeit Pharmacology Pharmaceutical sciences Counterfeit consumer goods

UPDATE